Cargando…

DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis

[Image: see text] Visceral leishmaniasis (VL) is a parasitic disease endemic across multiple regions of the world and is fatal if untreated. Current therapies are unsuitable, and there is an urgent need for safe, short-course, and low-cost oral treatments to combat this neglected disease. The benzox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mowbray, Charles E., Braillard, Stéphanie, Glossop, Paul A., Whitlock, Gavin A., Jacobs, Robert T., Speake, Jason, Pandi, Bharathi, Nare, Bakela, Maes, Louis, Yardley, Vanessa, Freund, Yvonne, Wall, Richard J., Carvalho, Sandra, Bello, Davide, Van den Kerkhof, Magali, Caljon, Guy, Gilbert, Ian H., Corpas-Lopez, Victoriano, Lukac, Iva, Patterson, Stephen, Zuccotto, Fabio, Wyllie, Susan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591608/ https://www.ncbi.nlm.nih.gov/pubmed/34711050 http://dx.doi.org/10.1021/acs.jmedchem.1c01437

Ejemplares similares

Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis
por: Wijnant, Gert-Jan, et al.
Publicado: (2019)

Film-Forming Systems for the Delivery of DNDI-0690 to Treat Cutaneous Leishmaniasis
por: Van Bocxlaer, Katrien, et al.
Publicado: (2021)

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis
por: Van Bocxlaer, Katrien, et al.
Publicado: (2019)

Heritability of Cardiovascular and Personality Traits in 6,148 Sardinians
por: Pilia, Giuseppe, et al.
Publicado: (2006)

In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series
por: Van den Kerkhof, M., et al.
Publicado: (2018)

Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance
por: Van den Kerkhof, M., et al.
Publicado: (2020)

Drug discovery and development for neglected diseases: the DNDi model
por: Chatelain, Eric, et al.
Publicado: (2011)

Pharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis
por: WRING, STEPHEN, et al.
Publicado: (2014)

SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis
por: Jacobs, Robert T., et al.
Publicado: (2011)

Development of (6R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis
por: Thompson, Andrew M., et al.
Publicado: (2018)

Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series
por: Van den Kerkhof, Magali, et al.
Publicado: (2021)

Identification of a 4-fluorobenzyl l-valinate amide benzoxaborole (AN11736) as a potential development candidate for the treatment of Animal African Trypanosomiasis (AAT)
por: Akama, Tsutomu, et al.
Publicado: (2018)

Benzoxaboroles—Novel Autotaxin Inhibitors
por: Kraljić, Kristina, et al.
Publicado: (2019)

Mechanochemical synthesis of antifungal bis(benzoxaboroles)
por: Borys, Krzysztof M., et al.
Publicado: (2020)

Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugs
por: Giordani, Federica, et al.
Publicado: (2020)

SophosQM: Accurate Binding Affinity Prediction in Compound Optimization
por: Guareschi, Riccardo, et al.
Publicado: (2023)

Utilizing thermal proteome profiling to identify the molecular targets of anti-leishmanial compounds
por: Corpas-Lopez, Victoriano, et al.
Publicado: (2021)

Ligand binding: evaluating the contribution of the water molecules network using the Fragment Molecular Orbital method
por: Lukac, Iva, et al.
Publicado: (2021)

Dye Displacement Assay for Saccharides using Benzoxaborole Hydrogels
por: Lampard, Emma V., et al.
Publicado: (2018)

Heteroelement Analogues of Benzoxaborole and Related Ring Expanded Systems
por: Nowicki, Krzysztof, et al.
Publicado: (2021)

The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosis
por: Korkegian, Aaron, et al.
Publicado: (2018)

Host-parasite co-metabolic activation of antitrypanosomal aminomethyl-benzoxaboroles
por: Zhang, Ning, et al.
Publicado: (2018)

The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing
por: Begolo, Daniela, et al.
Publicado: (2018)

Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
por: Lunde, Christopher S., et al.
Publicado: (2019)

Anti-parasitic benzoxaboroles are ineffective against Theileria parva in vitro
por: Steketee, Pieter C., et al.
Publicado: (2023)

Development of a Scalable Process for the Synthesis of DNDI-VL-2098: A Potential Preclinical Drug Candidate for the Treatment of Visceral Leishmaniasis
por: Satam, Vijay S., et al.
Publicado: (2016)

Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles
por: Zhang, Yong-Kang, et al.
Publicado: (2015)

Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei
por: Steketee, Pieter C., et al.
Publicado: (2018)

Clinically relevant benzoxaboroles inhibit mRNA processing in Trypanosoma brucei
por: Waithaka, Albina, et al.
Publicado: (2022)

5-Fluoro-1,3-dihydro-2,1-benzoxaborol-1-ol
por: Madura, Izabela D., et al.
Publicado: (2011)

Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles
por: Nocentini, Alessio, et al.
Publicado: (2017)

Synthesis and Influence of 3-Amino Benzoxaboroles Structure on Their Activity against Candida albicans
por: Wieczorek, Dorota, et al.
Publicado: (2020)

Synergy between dinotefuran and fipronil against the cat flea (Ctenocephalides felis): improved onset of action and residual speed of kill in adult cats
por: Delcombel, Romain, et al.
Publicado: (2017)

Cryptosporidium and Toxoplasma Parasites Are Inhibited by a Benzoxaborole Targeting Leucyl-tRNA Synthetase
por: Palencia, Andrés, et al.
Publicado: (2016)

A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis In Vitro
por: Patel, Nipul, et al.
Publicado: (2017)

Design and enantioselective synthesis of 3-(α-acrylic acid) benzoxaboroles to combat carbapenemase resistance
por: Xiao, You-Cai, et al.
Publicado: (2021)

Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates
por: Padilla, Angel M., et al.
Publicado: (2022)

Aggregation-Based Bacterial Separation with Gram-Positive Selectivity by Using a Benzoxaborole-Modified Dendrimer
por: Mikagi, Ayame, et al.
Publicado: (2023)

Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase
por: Hu, Qing-Hua, et al.
Publicado: (2013)

Facile Functionalization of Electrospun Poly(ethylene-co-vinyl alcohol) Nanofibers via the Benzoxaborole-Diol Interaction
por: Kotsuchibashi, Yohei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u0ptdmt7fc25gumtvto4s8o2ce